Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Idarubicin × Sarcoma × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 41 Myeloid 8 Lymphoid 8 Classical hematology 5 Plasma cell 3 Sarcoma 1

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Doxorubicin 38 Radiotherapy 27 Ifosfamide 26 Vincristine 25 Cyclophosphamide 21 Etoposide 19 Imatinib Mesylate 18 Radiation 12 Dactinomycin 12 Filgrastim 11 Temozolomide 9 Trabectedin 8 Sunitinib 8 Methotrexate 8 Specimen Handling 6 Granulocyte Colony-Stimulating Factor 6 pazopanib 5 nilotinib 5 Zoledronic Acid 5 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Cisplatin 5 Topotecan 4 Surgical Procedures, Operative 4 Procarbazine 4 Paclitaxel 4 Liposomes 4 Ibandronic Acid 4 Dexrazoxane 4 Dacarbazine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡